SCHEMBL9263371

SCHEMBL9263371

O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Cl)ccc3c21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 5/20 0.78
MAP3K9 P80192 4/20 0.78
PRKCA P17252 3/20 0.78
GLI1 P08151 2/20 0.78
GLI2 P10070 2/20 0.78
CDK4 P11802 2/20 0.78
CCND1 P24385 2/20 0.78
CAMK2B Q13554 2/20 0.78
CAMK2G Q13555 2/20 0.78
CAMK2D Q13557 2/20 0.78
CAMK2A Q9UQM7 2/20 0.78
PRKCQ Q04759 2/20 0.78
PRKCD Q05655 2/20 0.78
PRKD3 O94806 1/20 0.78
PRKCG P05129 1/20 0.78
PRKCB P05771 1/20 0.78
CTRB1 P17538 1/20 0.78
PRKACA P17612 1/20 0.78
PRKACG P22612 1/20 0.78
PRKACB P22694 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9270827 1.00 MAP3K11 (0.78) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL9264016 0.94 MAP3K11 (0.66) MAP3K11MAP3K9PRKCAGLI1GLI2
Staurosporinone SCHEMBL29374983 0.88 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAGLI1GLI2
Staurosporinone SCHEMBL29389399 0.88 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAGLI1GLI2
Staurosporinone SCHEMBL5440281 0.88 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL9265092 0.86 PARP1 (0.75) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL8127691 0.83 CDK4 (1.00) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL6627111 0.80 MAP3K9 (0.76) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL6627054 0.80 MAP3K9 (0.76) MAP3K11MAP3K9PRKCAGLI1GLI2
SCHEMBL22567012 0.78 MAP3K11 (0.66) MAP3K11MAP3K9PRKCAGLI1GLI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993024490-A1 USE OF INDOLOCARBAZOLS IN AIDS TREATMENT Gödecke Aktiengesellschaft (DE) 1993-12-09 WO claimed
US-5438050-A Indolocarbazole derivatives, processes for their preparation and compositions containing them GODECKE AKTIENGESELLSCHAFT (DE) 1995-08-01 US disclosed
WO-1993024490-A1 USE OF INDOLOCARBAZOLS IN AIDS TREATMENT Gödecke Aktiengesellschaft (DE) 1993-12-09 WO disclosed
EP-0370236-B1 INDOLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-12-27 EP disclosed
EP-0370236-A1 Indolocarbazole derivatives, processes for their preparation and their use as medicaments GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-05-30 EP disclosed